Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that ...

GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

GSK (GSK) used its third-quarter trading update to draw a definitive line under the damaging litigation around its now discontinued heartburn medicine Zantac, by agreeing a settlement earlier in ...

Pharmaceutical titan GSK has witnessed a profit tumble owing to charges linked with the litigation over Zantac, yet has reiterated its financial forecasts, stressing stability in the company's core ...

Safes are collectible mini-puzzles located in almost every level of the story — each safe has a randomly generated code. Input the correct code and you’ll find a stack of valuable cash.

Our quick take: The Capital One 360 Performance Savings account offers ... their savings through a highly-rated mobile app. Having a safe place for storing your money is key to giving you peace ...

Simply sign up to the Investment Banking myFT Digest -- delivered directly to your inbox. As year-end approaches, investment banks embark on one of their most hallowed (and often groaned-about ...

We have to consistently use memory safe languages and other protections when developing software to eliminate these weaknesses from malicious cyber actors.” That wasn’t the end of the matter ...

Around £2billion was added to the value of GSK after the pharmaceuticals giant agreed a £1.7billion settlement over claims that its heartburn medicine Zantac caused cancer. Shares rose 3.2 per ...

GSK agreed to pay $2.2 billion to settle approximately 80,000 lawsuits in U.S. courts over claims its heartburn drug, Zantac, caused cancer. The settlements account for 93% of all cases and were ...

The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...